Alpha Teknova

TKNO (NasdaqGM)

Alpha Teknova, Inc. develops and produces critical reagents for discovering, developing, and commercializing novel therapies, vaccines, and molecular diagnostics in the US and worldwide. Products include pre-poured cell culture media plates, liquid microbial media and supplements, and molecular biology reagents for sample preparation. It also supplies chemical formulations and custom clinical solutions for protein and gene therapies, mRNA vaccines, and diagnostic kits, serving pharma, biotech, CDMOs, IVD partners, and research institutions. Founded in 1996 and based in Hollister, California.